Kidney Cancer
Show only recruiting trials?

ZIRCON
A Confirmatory, Prospective, Open-label, Multi-centre Phase 3 Study to Evaluate Diagnostic Performance of Zirconium-labelled Girentuximab to Non-invasively Detect ccRCC by PET/CT Imaging in Patients With Indeterminate Renal Masses
Status
Recruiting
JCP
JCP092
NCT
NCT03849118

CheckMate 214
Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)
Status
Closed to Accrual
JCP
McG1224
NCT
NCT02231749
Filter Clinical Trials by:
Biomarkers: